Krognes Steve E.
Insider CIK 1666236 · GH Director · CRVS Director, 10% owner · GRTS Director · DNLI CFO and Treasurer, Director · PLRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 3,300 | $175.42 | $578.9K | 10,177 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 1,300 | $176.34 | $229.2K | 8,877 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 971 | $177.48 | $172.3K | 7,906 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 1,103 | $174.46 | $192.4K | 13,477 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 971 | $177.48 | $172.3K | 7,906 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 1,300 | $176.34 | $229.2K | 8,877 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 3,300 | $175.42 | $578.9K | 10,177 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 1,103 | $174.46 | $192.4K | 13,477 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-06-30 | 2026-07-02 | 155 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-06-30 | 2026-07-02 | 155 | — | $0 | 14,580 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-22 | 4,203 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 2,711 | — | $0 | 2,711 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-06-17 | 2026-06-22 | 4,203 | — | $0 | 14,425 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GH Guardant Health, Inc. | S Sale | 2026-06-04 | 2026-06-05 | 9,294 | $132.51 | $1.23M | 10,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 19,226 | — | $0 | 19,226 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-06-03 | 2026-06-05 | 6,408 | — | $0 | 38,202 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-05-31 | 2026-06-01 | 154 | — | $0 | 155 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-05-31 | 2026-06-01 | 154 | — | $0 | 19,516 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-04-30 | 2026-05-01 | 154 | — | $0 | 309 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-04-30 | 2026-05-01 | 154 | — | $0 | 19,362 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-03-31 | 2026-04-01 | 155 | — | $0 | 463 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-03-31 | 2026-04-01 | 155 | — | $0 | 19,208 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-02-28 | 2026-03-02 | 154 | — | $0 | 618 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-02-28 | 2026-03-02 | 154 | — | $0 | 19,053 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-02 | 154 | — | $0 | 772 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-01-31 | 2026-02-02 | 154 | — | $0 | 18,899 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 154 | — | $0 | 926 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 154 | — | $0 | 18,745 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-11-30 | 2025-12-01 | 155 | — | $0 | 1,080 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-11-30 | 2025-12-01 | 155 | — | $0 | 18,591 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-10-31 | 2025-11-03 | 154 | — | $0 | 1,235 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-10-31 | 2025-11-03 | 154 | — | $0 | 18,436 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-09-30 | 2025-10-02 | 154 | — | $0 | 1,389 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-09-30 | 2025-10-02 | 154 | — | $0 | 18,282 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-08-31 | 2025-09-03 | 155 | — | $0 | 1,543 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-08-31 | 2025-09-03 | 155 | — | $0 | 18,128 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-07-31 | 2025-08-04 | 154 | — | $0 | 1,698 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-07-31 | 2025-08-04 | 154 | — | $0 | 17,973 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 154 | — | $0 | 1,852 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 154 | — | $0 | 17,819 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 4,203 | — | $0 | 4,203 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 6,833 | — | $0 | 6,833 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-06-12 | 2025-06-16 | 6,674 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-06-12 | 2025-06-16 | 6,674 | — | $0 | 17,665 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 18,111 | — | $0 | 18,111 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-06-03 | 2025-06-05 | 6,037 | — | $0 | 31,794 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-05-31 | 2025-06-02 | 154 | — | $0 | 2,006 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-05-31 | 2025-06-02 | 154 | — | $0 | 10,991 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-04-30 | 2025-05-01 | 155 | — | $0 | 2,160 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-04-30 | 2025-05-01 | 155 | — | $0 | 10,837 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-03-31 | 2025-04-02 | 154 | — | $0 | 2,315 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-03-31 | 2025-04-02 | 154 | — | $0 | 10,682 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-02-28 | 2025-03-04 | 154 | — | $0 | 2,469 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-02-28 | 2025-03-04 | 154 | — | $0 | 10,528 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 154 | — | $0 | 2,623 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 154 | — | $0 | 10,374 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2025-01-07 | 2025-01-08 | 3,339 | $20.81 | $69.5K | 25,757 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-02 | 155 | — | $0 | 2,777 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-12-31 | 2025-01-02 | 155 | — | $0 | 10,220 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-12-31 | 2025-01-03 | 30,000 | $20.25 | $607.5K | 29,096 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-11-30 | 2024-12-02 | 154 | — | $0 | 2,932 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-11-30 | 2024-12-02 | 154 | — | $0 | 10,065 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-10-31 | 2024-11-04 | 154 | — | $0 | 3,086 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-10-31 | 2024-11-04 | 154 | — | $0 | 9,911 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-09-30 | 2024-10-01 | 154 | — | $0 | 3,240 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-09-30 | 2024-10-01 | 154 | — | $0 | 9,757 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-09-30 | 2024-10-02 | 30,000 | $29.03 | $870.9K | 29,096 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-08-31 | 2024-09-03 | 155 | — | $0 | 3,394 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-08-31 | 2024-09-03 | 155 | — | $0 | 9,603 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-08-20 | 2024-08-22 | 1,727 | $23.79 | $41.1K | 32,677 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-07-31 | 2024-08-01 | 154 | — | $0 | 3,549 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-07-31 | 2024-08-01 | 154 | — | $0 | 9,448 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-07-01 | 2024-07-03 | 29,900 | $22.12 | $661.4K | 34,504 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-07-01 | 2024-07-03 | 100 | $22.80 | $2.3K | 34,404 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-06-30 | 2024-07-02 | 154 | — | $0 | 3,703 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-06-30 | 2024-07-02 | 154 | — | $0 | 9,294 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-06-13 | 2024-07-03 | 688 | $21.79 | $15.0K | 52,620 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-06-13 | 2024-06-17 | 53,528 | — | $0 | 53,528 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 10,703 | — | $0 | 10,703 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-06-12 | 2024-06-13 | 5,592 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 6,674 | — | $0 | 6,674 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-06-12 | 2024-06-13 | 5,592 | — | $0 | 9,140 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-05-31 | 2024-06-03 | 155 | — | $0 | 3,857 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-05-31 | 2024-06-03 | 155 | — | $0 | 3,548 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 53,308 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-04-30 | 2024-05-02 | 154 | — | $0 | 4,012 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-04-30 | 2024-05-02 | 154 | — | $0 | 3,393 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-04-01 | 2024-04-02 | 92,500 | $20.50 | $1.90M | 47,341 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-03-31 | 2024-04-01 | 154 | — | $0 | 4,166 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-03-31 | 2024-04-01 | 154 | — | $0 | 3,239 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-01 | 154 | — | $0 | 4,320 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-02-29 | 2024-03-01 | 154 | — | $0 | 3,085 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-02-13 | 2024-02-15 | 2,750 | $17.29 | $47.5K | 139,841 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-01 | 155 | — | $0 | 4,474 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2024-01-31 | 2024-02-01 | 155 | — | $0 | 2,931 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-01-05 | 2024-01-09 | 3,208 | $19.43 | $62.3K | 142,591 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-12-31 | 2024-01-02 | 154 | — | $0 | 4,629 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-12-31 | 2024-01-02 | 154 | — | $0 | 2,776 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-11-30 | 2023-12-04 | 154 | — | $0 | 4,783 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-11-30 | 2023-12-04 | 154 | — | $0 | 2,622 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-10-31 | 2023-11-01 | 154 | — | $0 | 4,937 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-10-31 | 2023-11-01 | 154 | — | $0 | 2,468 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-09-30 | 2023-10-02 | 155 | — | $0 | 5,091 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-09-30 | 2023-10-02 | 155 | — | $0 | 2,314 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-08-31 | 2023-09-05 | 154 | — | $0 | 5,246 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-08-31 | 2023-09-05 | 154 | — | $0 | 2,159 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-08-21 | 2023-08-23 | 1,419 | $22.60 | $32.1K | 145,799 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-07-31 | 2023-08-01 | 154 | — | $0 | 5,400 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-07-31 | 2023-08-01 | 154 | — | $0 | 2,005 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2023-06-30 | 2023-07-05 | 1,851 | — | $0 | 5,554 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2023-06-30 | 2023-07-05 | 1,851 | — | $0 | 1,851 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 51,800 | — | $0 | 51,800 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 8,803 | — | $0 | 8,803 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 5,592 | — | $0 | 5,592 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 147,218 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-13 | 2023-02-15 | 2,119 | $30.10 | $63.8K | 143,002 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-02-08 | 2023-02-10 | 1,377 | $30.88 | $42.5K | 145,121 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2023-01-05 | 2023-01-09 | 2,970 | $28.44 | $84.5K | 146,498 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-08-19 | 2022-08-23 | 2,253 | $33.22 | $74.8K | 149,468 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2022-08-09 | 2022-08-11 | 7,405 | — | $0 | 7,405 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2022-08-09 | 2022-08-11 | 11,879 | — | $0 | 11,879 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2022-07-19 | 2022-07-21 | 62,500 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2022-07-19 | 2022-07-21 | 62,500 | $0.68 | $42.5K | 151,721 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-11 | 2022-02-15 | 2,560 | $34.69 | $88.8K | 120,221 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-02-09 | 2022-02-11 | 1,296 | $37.09 | $48.1K | 122,781 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-01-05 | 2022-01-07 | 2,225 | $44.75 | $99.6K | 124,077 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 93,000 | — | $0 | 93,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-01-03 | 2022-01-05 | 31,000 | — | $0 | 126,302 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 200 | $50.07 | $10.0K | 95,302 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-08-19 | 2021-08-23 | 2,085 | $49.52 | $103.2K | 95,502 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2021-06-18 | 2021-11-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-15 | 2021-03-16 | 32,326 | $62.04 | $2.01M | 854,416 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-15 | 2021-03-16 | 1,158 | $63.67 | $73.7K | 850,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-15 | 2021-03-16 | 13,258 | $61.16 | $810.9K | 886,742 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-15 | 2021-03-16 | 3,258 | $62.71 | $204.3K | 851,158 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-18 | 501 | $66.80 | $33.5K | 900,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-18 | 16,616 | $66.20 | $1.10M | 900,501 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-18 | 10,199 | $65.04 | $663.3K | 917,117 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-16 | 2021-02-18 | 22,684 | $64.27 | $1.46M | 927,316 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 2,635 | $70.17 | $184.9K | 97,987 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-11 | 2021-02-16 | 400 | $71.43 | $28.6K | 97,587 | SEC↗ |
| DNLI | S Sale | 2021-02-09 | 2021-02-11 | 1,022 | $74.38 | $76.0K | 13,405 | SEC↗ |
| DNLI | S Sale | 2021-02-09 | 2021-02-11 | 426 | $75.39 | $32.1K | 12,979 | SEC↗ |
| DNLI | M Exercise deriv | 2021-02-07 | 2021-02-11 | 4,250 | — | $0 | 8,500 | SEC↗ |
| DNLI | M Exercise | 2021-02-07 | 2021-02-11 | 4,250 | — | $0 | 14,427 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-15 | 2021-01-20 | 12,981 | $70.96 | $921.1K | 972,218 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-15 | 2021-01-20 | 8,071 | $71.99 | $581.0K | 964,147 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-15 | 2021-01-20 | 14,147 | $73.01 | $1.03M | 950,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-01-15 | 2021-01-20 | 14,801 | $70.10 | $1.04M | 985,199 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | F Tax w/h | 2020-08-21 | 2020-08-24 | 1,954 | $32.87 | $64.2K | 1,006,511 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-08-20 | 2020-08-24 | 5,643 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-08-20 | 2020-08-24 | 5,643 | — | $0 | 1,008,465 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-08-18 | 2020-08-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-06-09 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-03-30 | 2020-04-01 | 1,428 | $19.48 | $27.8K | 1,006,488 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-03-19 | 2020-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 29,143 | — | $0 | 29,143 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2020-02-07 | 2020-04-01 | 4,250 | — | $0 | 12,750 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2020-02-07 | 2020-04-01 | 4,250 | — | $0 | 1,007,916 | SEC↗ |
| DNLI Denali Therapeutics Inc. | F Tax w/h | 2019-08-21 | 2019-08-22 | 1,977 | $18.59 | $36.8K | 1,003,666 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2019-08-20 | 2019-08-22 | 5,643 | — | $0 | 5,643 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2019-08-20 | 2019-08-22 | 5,643 | — | $0 | 1,005,643 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-06-20 | 2019-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 8,570 | — | $0 | 8,570 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-07 | 2019-02-11 | 136,000 | — | $0 | 136,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-02-07 | 2019-02-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-08-20 | 2018-08-22 | 11,286 | — | $0 | 11,286 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-06-21 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-02-26 | 2018-02-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 500,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-12 | 500,000 | — | $0 | 1,000,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-06-08 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-03-22 | 2016-03-24 | 30,000 | — | $0 | 30,000 | SEC↗ |